|
G |
Arsb |
arylsulfatase B |
decreases abundance |
ISO |
ARSB protein results in decreased abundance of Chondroitin Sulfates |
CTD |
PMID:29794138 |
|
NCBI chr 2:25,002,210...25,162,675
Ensembl chr 2:25,002,346...25,162,671
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
multiple interactions |
EXP |
[icatibant binds to and results in decreased activity of BDKRB2 protein] which results in decreased susceptibility to Chondroitin Sulfates |
CTD |
PMID:21436127 |
|
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to BDNF protein |
CTD |
PMID:15385557 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
C3 |
complement C3 |
increases cleavage |
ISO |
Chondroitin Sulfates analog results in increased cleavage of C3 protein |
CTD |
PMID:18434646 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C5 |
complement C5 |
increases cleavage |
ISO |
Chondroitin Sulfates analog results in increased cleavage of C5 protein |
CTD |
PMID:18434646 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP3 protein]; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP3 mRNA] |
CTD |
PMID:17879260 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein]; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA] |
CTD |
PMID:17879260 |
|
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Chondroitin Sulfates inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] |
CTD |
PMID:12736501 PMID:15089041 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
affects binding |
ISO |
Chondroitin Sulfates binds to CCL2 protein |
CTD |
PMID:16385517 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL11 protein]; Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL9 protein]; Chondroitin Sulfates promotes the reaction [CTSB protein results in increased cleavage of benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide] |
CTD |
PMID:25833952 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSK protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide]; Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL2 protein]; Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL3 protein] |
CTD |
PMID:25833952 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Ctsl |
cathepsin L |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSL protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSL protein results in increased degradation of CXCL11 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL2 protein] |
CTD |
PMID:25833952 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Ctss |
cathepsin S |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSS protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL2 protein] |
CTD |
PMID:25833952 |
|
NCBI chr 2:183,089,192...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL1 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSK protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSL protein results in increased degradation of CXCL10 protein]; Chondroitin Sulfates inhibits the reaction [CTSS protein results in increased degradation of CXCL10 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL11 protein]; Chondroitin Sulfates inhibits the reaction [CTSL protein results in increased degradation of CXCL11 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL2 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL2 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL2 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [CTSK protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSL protein results in increased cleavage of CXCL1 protein]; Chondroitin Sulfates promotes the reaction [CTSS protein results in increased cleavage of CXCL1 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
ISO |
Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL9 protein] |
CTD |
PMID:25833952 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
F12 |
coagulation factor XII |
increases activity |
ISO |
Chondroitin Sulfates analog results in increased activity of F12 protein |
CTD |
PMID:18434646 |
|
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein; Chondroitin Sulfates analog binds to FGF10 protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr 2:50,801,897...50,875,428
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf16 |
fibroblast growth factor 16 |
affects binding |
EXP |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF16 protein; Chondroitin Sulfates analog binds to FGF16 protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr X:70,816,658...70,827,270
Ensembl chr X:70,817,433...70,878,717
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF18 protein; Chondroitin Sulfates analog binds to FGF18 protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein; Chondroitin Sulfates analog binds to FGF2 protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
increases activity |
ISO |
Chondroitin Sulfates analog results in increased activity of FGF23 protein |
CTD |
PMID:16081635 |
|
NCBI chr 4:159,914,393...159,922,073
Ensembl chr 4:159,914,272...159,923,821
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to GDNF protein |
CTD |
PMID:15385557 |
|
NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to HBEGF protein; Chondroitin Sulfates analog binds to HBEGF protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGES protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein; [Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in increased expression of TIMP3 mRNA; [Glucosamine co-treated with Chondroitin Sulfates] inhibits the reaction [IL1B protein results in increased secretion of Dinoprostone]; [Glucosamine co-treated with Chondroitin Sulfates] inhibits the reaction [IL1B protein results in increased secretion of Nitrites] |
CTD |
PMID:17605605 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
multiple interactions |
ISO |
TNFAIP6 protein promotes the reaction [ITIH1 protein binds to Chondroitin Sulfates] |
CTD |
PMID:25561734 |
|
NCBI chr16:6,122,246...6,136,363
Ensembl chr16:6,122,248...6,136,363
|
|
G |
Klkb1 |
kallikrein B1 |
increases activity |
ISO |
Chondroitin Sulfates analog results in increased activity of KLKB1 protein |
CTD |
PMID:18434646 |
|
NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
|
|
G |
Mdk |
midkine |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein; Chondroitin Sulfates analog binds to MDK protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr 3:77,901,156...77,903,997
Ensembl chr 3:77,901,158...77,903,130
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates] results in decreased expression of MMP3 mRNA; [Glucosamine co-treated with Chondroitin Sulfates] results in decreased secretion of MMP3 protein |
CTD |
PMID:20110869 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
[Chondroitin Sulfates co-treated with Hyaluronic Acid] inhibits the reaction [Carbon Tetrachloride results in increased activity of MPO protein] |
CTD |
PMID:14697411 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of NFKB1 protein] |
CTD |
PMID:17879260 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in decreased expression of NFKBIA protein] |
CTD |
PMID:17879260 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of NOS2 protein |
CTD |
PMID:17605605 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]; Genistein inhibits the reaction [Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]] |
CTD |
PMID:16945567 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions |
ISO |
Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]; Genistein inhibits the reaction [Chondroitin Sulfates promotes the reaction [PDGFB protein results in increased phosphorylation of and results in increased activity of PDGFRB protein]] |
CTD |
PMID:16945567 |
|
NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Ptges |
prostaglandin E synthase |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGES protein |
CTD |
PMID:17605605 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in decreased expression of PTGS2 protein |
CTD |
PMID:17605605 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptn |
pleiotrophin |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein; Chondroitin Sulfates analog binds to PTN protein |
CTD |
PMID:12221095 PMID:15385557 |
|
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
affects binding |
ISO |
PTPN11 protein binds to Chondroitin Sulfates |
CTD |
PMID:29794138 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of RELA protein] |
CTD |
PMID:17879260 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
multiple interactions |
ISO |
[Glucosamine co-treated with Chondroitin Sulfates co-treated with IL1B protein] results in increased expression of TIMP3 mRNA |
CTD |
PMID:17605605 |
|
NCBI chr 7:17,520,827...17,571,871
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP ISO |
[Chondroitin Sulfates co-treated with Hyaluronic Acid] inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein] [Glucosamine co-treated with Chondroitin Sulfates] results in decreased expression of TNF |
CTD |
PMID:14697411 PMID:20110869 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
multiple interactions |
ISO |
TNFAIP6 protein promotes the reaction [ITIH1 protein binds to Chondroitin Sulfates] |
CTD |
PMID:25561734 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
multiple interactions increases expression |
ISO |
[Chondroitin Sulfates co-treated with Cholecalciferol] results in increased expression of TNFRSF11B mRNA; [Chondroitin Sulfates co-treated with Cholecalciferol] results in increased expression of TNFRSF11B protein; [Chondroitin Sulfates co-treated with Glucosamine co-treated with Cholecalciferol] results in increased expression of TNFRSF11B mRNA; [Chondroitin Sulfates co-treated with Glucosamine co-treated with Cholecalciferol] results in increased expression of TNFRSF11B protein; [Chondroitin Sulfates co-treated with Glucosamine] results in increased expression of TNFRSF11B mRNA; [Chondroitin Sulfates co-treated with Glucosamine] results in increased expression of TNFRSF11B protein Chondroitin Sulfates results in increased expression of TNFRSF11B protein |
CTD |
PMID:17996099 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions decreases expression |
ISO |
[Chondroitin Sulfates co-treated with Glucosamine] inhibits the reaction [Cholecalciferol results in increased expression of TNFSF11 mRNA]; Chondroitin Sulfates inhibits the reaction [Cholecalciferol results in increased expression of TNFSF11 mRNA]; Chondroitin Sulfates inhibits the reaction [Glucosamine results in increased expression of TNFSF11 mRNA] Chondroitin Sulfates results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:17996099 |
|
NCBI chr15:53,674,990...53,705,171
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Vegfa |
vascular endothelial growth factor A |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to VEGFA protein |
CTD |
PMID:15385557 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to BDNF protein |
CTD |
PMID:15385557 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
F2 |
coagulation factor II |
multiple interactions |
ISO |
[Dermatan Sulfate co-treated with SERPIND1 protein] results in decreased activity of F2 protein |
CTD |
PMID:11805133 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF10 protein |
CTD |
PMID:15385557 |
|
NCBI chr 2:50,801,897...50,875,428
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf16 |
fibroblast growth factor 16 |
affects binding |
EXP |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF16 protein |
CTD |
PMID:15385557 |
|
NCBI chr X:70,816,658...70,827,270
Ensembl chr X:70,817,433...70,878,717
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF18 protein |
CTD |
PMID:15385557 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
affects binding increases activity |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein Dermatan Sulfate analog results in increased activity of FGF2 protein |
CTD |
PMID:15385557 PMID:15563459 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
increases activity |
ISO |
Dermatan Sulfate analog results in increased activity of FGF23 protein |
CTD |
PMID:16081635 |
|
NCBI chr 4:159,914,393...159,922,073
Ensembl chr 4:159,914,272...159,923,821
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
increases activity |
ISO |
Dermatan Sulfate analog results in increased activity of FGF7 protein |
CTD |
PMID:15563459 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to GDNF protein |
CTD |
PMID:15385557 |
|
NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to HBEGF protein |
CTD |
PMID:15385557 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Mdk |
midkine |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to MDK protein |
CTD |
PMID:15385557 |
|
NCBI chr 3:77,901,156...77,903,997
Ensembl chr 3:77,901,158...77,903,130
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
decreases expression |
ISO |
Dermatan Sulfate results in decreased expression of PDGFRA mRNA |
CTD |
PMID:16945567 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
decreases expression |
ISO |
Dermatan Sulfate results in decreased expression of PDGFRB mRNA |
CTD |
PMID:16945567 |
|
NCBI chr18:54,500,002...54,538,843
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Ptn |
pleiotrophin |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to PTN protein |
CTD |
PMID:15385557 |
|
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
|
|
G |
Serpind1 |
serpin family D member 1 |
multiple interactions |
ISO |
[Dermatan Sulfate co-treated with SERPIND1 protein] results in decreased activity of F2 protein |
CTD |
PMID:11805133 |
|
NCBI chr11:83,664,517...83,675,593
Ensembl chr11:83,664,518...83,675,519
|
|
G |
Vegfa |
vascular endothelial growth factor A |
affects binding |
ISO |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to VEGFA protein |
CTD |
PMID:15385557 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of [CCL5 protein binds to CCL5 protein]]; Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of CCL5 protein] |
CTD |
PMID:21963154 |
|
NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
CXCL10 protein inhibits the reaction [CXCL1 protein binds to Heparitin Sulfate] |
CTD |
PMID:12549928 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
CXCL10 protein inhibits the reaction [CXCL1 protein binds to Heparitin Sulfate] |
CTD |
PMID:12549928 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
CXCL10 protein inhibits the reaction [CXCL1 protein binds to Heparitin Sulfate] |
CTD |
PMID:12549928 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
affects binding |
ISO |
FGF1 protein binds to Heparitin Sulfate binds to FGFR1 protein |
CTD |
PMID:12604602 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects activity |
ISO |
Heparitin Sulfate affects the activity of FGF10 protein |
CTD |
PMID:12781692 PMID:12818887 |
|
NCBI chr 2:50,801,897...50,875,428
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions affects binding increases activity |
ISO |
Heparitin Sulfate binds to and affects the activity of FGF2 protein Heparitin Sulfate binds to FGF2 protein Heparitin Sulfate analog results in increased activity of FGF2 protein |
CTD |
PMID:12460940 PMID:15464572 PMID:15958608 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf4 |
fibroblast growth factor 4 |
affects binding |
ISO |
Heparitin Sulfate binds to FGF4 protein |
CTD |
PMID:15769253 |
|
NCBI chr 1:200,023,937...200,027,793
Ensembl chr 1:200,024,056...200,025,466
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
affects binding |
ISO |
Heparitin Sulfate binds to FGF7 protein |
CTD |
PMID:15769253 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
affects binding increases activity |
ISO |
Heparitin Sulfate binds to FGF8 protein alternative form Heparitin Sulfate analog results in increased activity of FGF8 protein |
CTD |
PMID:12460940 PMID:15769253 |
|
NCBI chr 1:244,584,477...244,590,359
Ensembl chr 1:244,584,652...244,590,359
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
affects binding increases activity |
ISO |
FGF1 protein binds to Heparitin Sulfate binds to FGFR1 protein Heparitin Sulfate analog results in increased activity of FGFR1 protein alternative form |
CTD |
PMID:12460940 PMID:12604602 |
|
NCBI chr16:66,492,445...66,546,731
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
decreases activity |
ISO |
Heparitin Sulfate analog results in decreased activity of FGFR2 protein mutant form |
CTD |
PMID:16373332 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
increases activity |
ISO |
Heparitin Sulfate analog results in increased activity of FGFR3 protein alternative form |
CTD |
PMID:12460940 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
affects binding |
ISO |
Heparitin Sulfate analog binds to FGFR4 protein |
CTD |
PMID:11278860 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
affects degradation |
ISO |
GNS affects the degradation of Heparitin Sulfate |
CTD |
PMID:3391615 |
|
NCBI chr 7:56,889,139...56,923,170
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Gpc1 |
glypican 1 |
affects binding multiple interactions |
ISO |
GPC1 protein binds to Heparitin Sulfate GPC1 protein modified form results in increased cleavage of [GPC1 protein binds to Heparitin Sulfate]; nitroxyl affects the reaction [GPC1 protein results in increased cleavage of [GPC1 protein binds to Heparitin Sulfate]]; Zinc affects the reaction [GPC1 protein results in increased cleavage of [GPC1 protein binds to Heparitin Sulfate]] |
CTD |
PMID:12732622 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Hpse |
heparanase |
multiple interactions decreases abundance affects abundance |
ISO EXP |
[Heparin results in decreased activity of HPSE protein] which affects the abundance of Heparitin Sulfate; [phosphomannopentaose sulfate results in decreased activity of HPSE protein] which affects the abundance of Heparitin Sulfate HPSE protein results in decreased abundance of Heparitin Sulfate HPSE protein affects the abundance of Heparitin Sulfate |
CTD |
PMID:16899518 PMID:17121850 |
|
NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:19937756 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:19937756 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Ndst1 |
N-deacetylase and N-sulfotransferase 1 |
multiple interactions |
ISO |
Heparitin Sulfate affects the susceptibility to [NDST1 protein co-treated with NDST2 protein]; Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK1 protein]; Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:19937756 |
|
NCBI chr18:54,136,887...54,199,545
Ensembl chr18:54,140,779...54,178,191
|
|
G |
Ndst2 |
N-deacetylase and N-sulfotransferase 2 |
multiple interactions |
ISO |
Heparitin Sulfate affects the susceptibility to [NDST1 protein co-treated with NDST2 protein]; Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK1 protein]; Heparitin Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:19937756 |
|
NCBI chr15:3,563,358...3,573,801
Ensembl chr15:3,563,358...3,573,801
|
|
G |
Prnp |
prion protein |
affects binding |
ISO |
PRNP protein modified form binds to Heparitin Sulfate metabolite |
CTD |
PMID:18717736 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
multiple interactions |
ISO |
[N6L peptide binds to Heparitin Sulfate] which results in increased secretion of TIMP3 protein |
CTD |
PMID:23109338 |
|
NCBI chr 7:17,520,827...17,571,871
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Heparitin Sulfate promotes the reaction [Dipyridamole results in increased secretion of VEGFA protein] |
CTD |
PMID:20067761 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
affects activity multiple interactions |
ISO |
Heparin affects the activity of ABCC1 protein Heparin affects the reaction [ABCC1 protein affects the transport of Doxorubicin] |
CTD |
PMID:17352253 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ACKR3 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
Heparin analog inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:16904936 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actr3 |
actin related protein 3 |
increases expression |
EXP |
Heparin results in increased expression of ACTR3 protein |
CTD |
PMID:17488504 |
|
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ADAMTS1 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
Heparin inhibits the reaction [AGT protein affects the localization of Calcium] |
CTD |
PMID:21613610 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of AKT1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:14966081 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
EXP |
Heparin results in increased expression of ANXA6 protein |
CTD |
PMID:17488504 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Apcs |
amyloid P component, serum |
increases expression |
ISO |
Heparin results in increased expression of APCS protein |
CTD |
PMID:17162433 |
|
NCBI chr13:85,373,338...85,374,134
Ensembl chr13:85,373,220...85,374,298
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
Copper promotes the reaction [Heparin binds to APP protein]; Zinc promotes the reaction [Heparin binds to APP protein] |
CTD |
PMID:25835329 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
increases expression |
EXP |
Heparin results in increased expression of ARHGDIA protein |
CTD |
PMID:17488504 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATP1B1 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
Heparin results in increased expression of BAX protein Heparin inhibits the reaction [arsenite results in increased expression of BAX protein] |
CTD |
PMID:11787776 PMID:26677073 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
ISO |
Heparin results in increased expression of BCL2 protein Heparin inhibits the reaction [arsenite results in decreased expression of BCL2 protein] |
CTD |
PMID:11787776 PMID:15205081 PMID:15671997 PMID:26677073 |
|
NCBI chr13:22,689,783...22,853,920
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
multiple interactions decreases expression |
ISO |
Heparin inhibits the reaction [BMP6 protein results in increased expression of HAMP mRNA]; Heparin inhibits the reaction [BMP6 protein results in increased secretion of HAMP protein modified form] Heparin results in decreased expression of BMP6 mRNA |
CTD |
PMID:25633564 |
|
NCBI chr17:26,318,121...26,469,034
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bmpr1a |
bone morphogenetic protein receptor type 1A |
decreases expression |
ISO |
Heparin results in decreased expression of BMPR1A mRNA |
CTD |
PMID:25633564 |
|
NCBI chr16:9,736,390...9,829,825
Ensembl chr16:9,736,630...9,780,616
|
|
G |
C3 |
complement C3 |
decreases expression |
ISO |
Heparin results in decreased expression of C3 protein |
CTD |
PMID:7948777 PMID:10568115 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C5 |
complement C5 |
decreases expression |
ISO |
Heparin results in decreased expression of C5 protein |
CTD |
PMID:7948777 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
Cacna1e |
calcium voltage-gated channel subunit alpha1 E |
multiple interactions |
EXP |
Heparin affects the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]] |
CTD |
PMID:12663092 |
|
NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
EXP |
Heparin results in increased expression of CAPG protein |
CTD |
PMID:17488504 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO |
Heparin inhibits the reaction [Paraoxon results in increased expression of CASP12 protein] |
CTD |
PMID:20079824 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
decreases activity multiple interactions |
ISO EXP |
Heparin results in decreased activity of CASP3 protein Heparin promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; Lithium Chloride inhibits the reaction [Heparin promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]] |
CTD |
PMID:16556679 PMID:30377735 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
increases activity |
ISO |
Heparin results in increased activity of CAT protein |
CTD |
PMID:12218949 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
affects binding multiple interactions |
ISO |
Heparin binds to CCL11 protein Heparin inhibits the reaction [PLG protein affects the degradation of CCL11 protein] |
CTD |
PMID:17384413 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
Heparin results in decreased expression of CCL2 protein |
CTD |
PMID:11053056 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd40lg |
CD40 ligand |
decreases expression |
ISO |
Heparin results in decreased expression of CD40LG protein |
CTD |
PMID:16391376 |
|
NCBI chr X:135,127,119...135,138,302
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
Heparin results in increased expression of CDKN1A protein |
CTD |
PMID:10926548 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression increases expression |
ISO |
Heparin analog results in decreased expression of CDKN1B protein Heparin analog results in increased expression of CDKN1B protein |
CTD |
PMID:18057711 PMID:20201787 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
affects binding |
ISO |
Heparin binds to COL18A1 protein alternative form |
CTD |
PMID:15604266 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Crp |
C-reactive protein |
increases expression |
ISO |
Heparin results in increased expression of CRP protein |
CTD |
PMID:16391376 |
|
NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf3 |
colony stimulating factor 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of CSF3 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
Heparin promotes the reaction [Doxorubicin results in decreased expression of CTNNB1 protein]; Lithium Chloride inhibits the reaction [Heparin promotes the reaction [Doxorubicin results in decreased expression of CTNNB1 protein]] |
CTD |
PMID:30377735 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
EXP |
Heparin inhibits the reaction [endotoxin, Escherichia coli results in increased expression of CXCL10 mRNA] |
CTD |
PMID:31813902 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
Heparin analog results in decreased expression of CXCL12 mRNA; Heparin analog results in decreased expression of CXCL12 protein |
CTD |
PMID:20201787 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of CXCL2 mRNA]; Heparin inhibits the reaction [Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of CXCL2 protein]] |
CTD |
PMID:16401727 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
decreases expression |
ISO |
Heparin analog results in decreased expression of CXCR4 mRNA; Heparin analog results in decreased expression of CXCR4 protein |
CTD |
PMID:20201787 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Ddah2 |
dimethylarginine dimethylaminohydrolase 2 |
decreases expression |
EXP |
Heparin results in decreased expression of DDAH2 protein |
CTD |
PMID:17488504 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Des |
desmin |
decreases expression |
EXP |
Heparin results in decreased expression of DES protein |
CTD |
PMID:9111513 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Heparin analog results in decreased expression of E2F1 protein |
CTD |
PMID:20201787 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions decreases expression decreases secretion |
ISO EXP |
Heparin inhibits the reaction [F2 protein results in increased expression of EDN1 mRNA]; Heparin inhibits the reaction [F2 protein results in increased secretion of EDN1 protein] Heparin results in decreased expression of EDN1 mRNA Heparin inhibits the reaction [EDN1 protein results in increased abundance of Calcium]; Heparin inhibits the reaction [EDN1 protein results in increased abundance of Inositol 1,4,5-Trisphosphate] Heparin results in decreased secretion of EDN1 protein |
CTD |
PMID:1443220 PMID:7509996 PMID:8408661 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egf |
epidermal growth factor |
decreases activity |
ISO |
Heparin results in decreased activity of EGF protein |
CTD |
PMID:12714831 |
|
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression increases phosphorylation |
ISO |
Heparin results in decreased expression of EGFR mRNA; Heparin results in decreased expression of EGFR protein Heparin results in increased phosphorylation of EGFR protein |
CTD |
PMID:16475731 PMID:16556679 |
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
F10 |
coagulation factor X |
decreases activity |
ISO EXP |
Heparin results in decreased activity of F10 protein |
CTD |
PMID:8950779 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F2 |
coagulation factor II |
multiple interactions decreases expression increases expression |
ISO |
F2 protein promotes the reaction [Heparin results in increased abundance of Nitric Oxide]; Heparin deficiency results in increased cleavage of and results in increased activity of F2 protein; Heparin deficiency results in increased expression of [SERPINC1 protein binds to F2 protein]; Heparin inhibits the reaction [F2 protein affects the localization of SELP protein]; Heparin inhibits the reaction [F2 protein results in increased cleavage of F2R protein]; Heparin inhibits the reaction [F2 protein results in increased expression of EDN1 mRNA]; Heparin inhibits the reaction [F2 protein results in increased secretion of EDN1 protein] Heparin results in increased expression of [F2 protein binds to SERPINC1 protein] Heparin results in decreased expression of F2 protein Heparin deficiency results in increased expression of F2 protein; Heparin results in increased expression of F2 protein |
CTD |
PMID:7509996 PMID:7895349 PMID:8408661 PMID:9740346 PMID:11869846 PMID:16391376 PMID:16961586 PMID:19468011 More...
|
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
multiple interactions |
ISO |
Heparin inhibits the reaction [F2 protein results in increased cleavage of F2R protein] |
CTD |
PMID:19468011 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Heparin results in increased expression of FAS protein |
CTD |
PMID:15205081 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
affects binding |
ISO |
[Heparin binds to PF4 protein] which binds to FCGR2A protein |
CTD |
PMID:8282825 |
|
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Fga |
fibrinogen alpha chain |
increases cleavage |
ISO |
Heparin deficiency results in increased cleavage of FGA protein |
CTD |
PMID:7895349 |
|
NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions affects binding |
ISO EXP |
[Heparin analog binds to FGFR2 protein alternative form] which binds to and results in increased activity of FGF1 protein; Heparin analog promotes the reaction [FGF1 protein binds to FGF1 protein] [Heparin binds to FGFR2 protein alternative form] which binds to FGF1 protein Heparin affects the reaction [FGF1 protein binds to FGFR4 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of AKT1 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K1 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K2 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK1 protein]; Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK3 protein]; Heparin promotes the reaction [FGF1 protein results in increased expression of FGF1 protein] Heparin promotes the reaction [FGFR1 protein binds to FGF1 protein]; Heparin promotes the reaction [FGFR3 protein binds to FGF1 protein] |
CTD |
PMID:1379594 PMID:8576258 PMID:10336501 PMID:10860838 PMID:14966081 PMID:16219767 More...
|
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
multiple interactions |
ISO |
Heparin promotes the reaction [FGF10 protein binds to FGFR2 protein] |
CTD |
PMID:15632068 |
|
NCBI chr 2:50,801,897...50,875,428
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
affects binding multiple interactions |
ISO |
Heparin binds to FGF19 protein Heparin promotes the reaction [FGF19 protein binds to FGFR4 protein] |
CTD |
PMID:10525310 PMID:14730967 |
|
NCBI chr 1:200,056,656...200,059,944
Ensembl chr 1:200,056,644...200,060,287
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
affects binding decreases expression multiple interactions affects activity |
ISO EXP |
Heparin binds to FGF2 protein; Heparin binds to FGFR1 protein binds to FGF2 protein Heparin results in decreased expression of FGF2 protein [Heparin binds to FGFR2 protein alternative form] which binds to FGF2 protein Heparin affects the reaction [FGF2 protein binds to FGFR4 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K2 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] Heparin affects the activity of FGF2 protein Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein]; Heparin promotes the reaction [FGFR2 protein binds to FGF2 protein] |
CTD |
PMID:1373495 PMID:1379594 PMID:8441232 PMID:10336501 PMID:10860838 PMID:14966081 PMID:15096041 PMID:15232299 PMID:17524524 More...
|
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
increases activity |
ISO |
Heparin analog results in increased activity of FGF23 protein |
CTD |
PMID:16081635 |
|
NCBI chr 4:159,914,393...159,922,073
Ensembl chr 4:159,914,272...159,923,821
|
|
G |
Fgf3 |
fibroblast growth factor 3 |
affects activity |
ISO |
Heparin affects the activity of FGF3 protein |
CTD |
PMID:7592624 |
|
NCBI chr 1:200,001,261...200,005,187
Ensembl chr 1:200,001,261...200,005,187
|
|
G |
Fgf4 |
fibroblast growth factor 4 |
multiple interactions |
ISO |
Heparin binds to and results in increased activity of FGF4 protein |
CTD |
PMID:11486033 |
|
NCBI chr 1:200,023,937...200,027,793
Ensembl chr 1:200,024,056...200,025,466
|
|
G |
Fgf5 |
fibroblast growth factor 5 |
affects activity |
ISO |
Heparin affects the activity of FGF5 protein |
CTD |
PMID:8386828 |
|
NCBI chr14:11,325,334...11,346,570
Ensembl chr14:11,325,334...11,345,997
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
affects binding |
EXP |
[Heparin binds to FGFR2 protein alternative form] which binds to FGF7 protein |
CTD |
PMID:10860838 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
affects binding multiple interactions |
ISO |
Heparin binds to FGFR1 protein binds to FGF2 protein Heparin promotes the reaction [FGFR1 protein binds to FGF1 protein]; Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein] |
CTD |
PMID:1379594 PMID:15096041 |
|
NCBI chr16:66,492,445...66,546,731
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
multiple interactions affects binding affects activity |
ISO EXP |
[Heparin analog binds to FGFR2 protein alternative form] which binds to and results in increased activity of FGF1 protein; Heparin promotes the reaction [FGF10 protein binds to FGFR2 protein] [Heparin binds to FGFR2 protein alternative form] which binds to FGF1 protein; [Heparin binds to FGFR2 protein alternative form] which binds to FGF2 protein; [Heparin binds to FGFR2 protein alternative form] which binds to FGF7 protein Heparin promotes the reaction [FGFR2 protein binds to FGF2 protein] Heparin affects the activity of FGFR2 protein |
CTD |
PMID:1373495 PMID:10860838 PMID:15632068 PMID:16219767 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
affects activity multiple interactions |
ISO |
Heparin affects the activity of FGFR3 protein Heparin promotes the reaction [FGFR3 protein binds to FGF1 protein] |
CTD |
PMID:1379594 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
affects binding multiple interactions |
ISO EXP |
Heparin analog binds to FGFR4 protein Heparin affects the reaction [FGF1 protein binds to FGFR4 protein]; Heparin affects the reaction [FGF2 protein binds to FGFR4 protein] Heparin promotes the reaction [FGF19 protein binds to FGFR4 protein]; Heparin promotes the reaction [FGFR4 protein binds to FGFR4 protein] |
CTD |
PMID:10336501 PMID:10525310 PMID:10736564 PMID:11278860 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression decreases expression multiple interactions |
ISO EXP |
Heparin results in increased expression of FOS protein Heparin results in decreased expression of FOS mRNA Heparin inhibits the reaction [4-O-methyl-12-O-tetradecanoylphorbol 13-acetate results in increased expression of FOS mRNA] |
CTD |
PMID:2099192 PMID:9083085 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gata4 |
GATA binding protein 4 |
multiple interactions |
EXP |
Heparin inhibits the reaction [Inositol 1,4,5-Trisphosphate results in increased expression of GATA4 protein] |
CTD |
PMID:16259952 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
affects degradation |
ISO |
GNS affects the degradation of Heparin |
CTD |
PMID:3391615 |
|
NCBI chr 7:56,889,139...56,923,170
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
Heparin inhibits the reaction [Diclofenac promotes the reaction [endotoxin, Escherichia coli results in increased activity of GPT protein]] |
CTD |
PMID:31813902 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gzmb |
granzyme B |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of GZMB mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr15:30,343,361...30,346,792
Ensembl chr15:30,173,603...30,346,814
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
decreases expression decreases secretion multiple interactions |
ISO |
Heparin results in decreased expression of HAMP mRNA Heparin results in decreased secretion of HAMP protein modified form Heparin inhibits the reaction [BMP6 protein results in increased expression of HAMP mRNA]; Heparin inhibits the reaction [BMP6 protein results in increased secretion of HAMP protein modified form]; Heparin inhibits the reaction [IL6 protein results in increased expression of HAMP mRNA] |
CTD |
PMID:25633564 PMID:25686467 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions affects binding increases expression |
ISO |
Heparin promotes the reaction [HGF protein binds to and results in increased activity of MET protein] HGF protein binds to Heparin Heparin results in increased expression of HGF protein |
CTD |
PMID:9083085 PMID:18243369 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [endotoxin, Escherichia coli results in increased expression of HMOX1 mRNA] |
CTD |
PMID:31813902 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hpse |
heparanase |
multiple interactions |
ISO |
[Heparin results in decreased activity of HPSE protein] which affects the abundance of Heparitin Sulfate |
CTD |
PMID:17121850 |
|
NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010
|
|
G |
Hrg |
histidine-rich glycoprotein |
multiple interactions |
ISO |
Heparin inhibits the reaction [Zinc results in increased activity of HRG protein] |
CTD |
PMID:8690451 |
|
NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
|
|
G |
Igsf10 |
immunoglobulin superfamily, member 10 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IGSF10 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:143,576,070...143,604,773
|
|
G |
Il6 |
interleukin 6 |
increases expression increases secretion multiple interactions |
ISO EXP |
Heparin results in increased expression of IL6 protein Heparin analog results in increased secretion of IL6 protein Heparin inhibits the reaction [IL6 protein results in increased expression of HAMP mRNA] Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of IL6 mRNA] |
CTD |
PMID:16391376 PMID:16401727 PMID:25633564 PMID:26476401 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgam |
integrin subunit alpha M |
decreases expression increases expression |
ISO |
Heparin results in decreased expression of ITGAM protein Heparin results in increased expression of ITGAM protein |
CTD |
PMID:8595612 PMID:8993250 |
|
NCBI chr 1:182,659,047...182,709,495
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgax |
integrin subunit alpha X |
decreases expression |
ISO |
Heparin results in decreased expression of ITGAX protein |
CTD |
PMID:8993250 |
|
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Heparin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of JUN protein] |
CTD |
PMID:1730747 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Klf4 |
Kruppel like factor 4 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of KLF4 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Krt18 |
keratin 18 |
increases expression |
ISO |
Heparin results in increased expression of KRT18 protein |
CTD |
PMID:15671997 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Ldhb |
lactate dehydrogenase B |
decreases expression |
EXP |
Heparin results in decreased expression of LDHB protein |
CTD |
PMID:17488504 |
|
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions |
EXP |
[etofibrate co-treated with Heparin] results in increased secretion of LPL protein |
CTD |
PMID:3179329 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K1 protein] |
CTD |
PMID:14966081 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
multiple interactions |
EXP |
Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAP2K2 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K2 protein] |
CTD |
PMID:14966081 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases activity |
ISO EXP |
Heparin analog inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] Heparin inhibits the reaction [sodium chlorate results in decreased phosphorylation of MAPK1 protein] Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK1 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] Heparin results in increased activity of MAPK1 protein |
CTD |
PMID:14966081 PMID:16556679 PMID:18057711 PMID:19937756 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases activity |
ISO EXP |
Heparin analog inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] Heparin inhibits the reaction [sodium chlorate results in decreased phosphorylation of MAPK3 protein] Heparin inhibits the reaction [FGF1 protein results in increased phosphorylation of MAPK3 protein]; Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] Heparin results in increased activity of MAPK3 protein |
CTD |
PMID:14966081 PMID:16556679 PMID:18057711 PMID:19937756 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
Heparin promotes the reaction [MAPT protein binds to MAPT protein]; Mercuric Chloride promotes the reaction [Heparin promotes the reaction [MAPT protein binds to MAPT protein]] |
CTD |
PMID:20665688 PMID:31678113 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mcpt4 |
mast cell protease 4 |
increases activity |
EXP |
Heparin increases activity of Mcpt4 protein |
RGD |
PMID:11896050 |
RGD:633287 |
NCBI chr15:29,501,595...29,504,216
Ensembl chr15:29,501,595...29,504,214
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
multiple interactions |
ISO |
Heparin promotes the reaction [HGF protein binds to and results in increased activity of MET protein] |
CTD |
PMID:9083085 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mif |
macrophage migration inhibitory factor |
affects binding |
ISO |
MIF protein binds to Heparin |
CTD |
PMID:26852939 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
decreases activity |
ISO |
Heparin results in decreased activity of MMP1 protein |
CTD |
PMID:10958381 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
decreases expression |
ISO |
Heparin analog results in decreased expression of MMP14 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases activity |
ISO |
Heparin results in decreased activity of MMP2 protein |
CTD |
PMID:10958381 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases activity increases expression multiple interactions |
ISO |
Heparin results in decreased activity of MMP9 protein Heparin results in increased expression of MMP9 mRNA; Heparin results in increased expression of MMP9 protein Heparin results in increased metabolism of and results in increased activity of MMP9 protein |
CTD |
PMID:10958381 PMID:14630814 PMID:16190367 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Heparin inhibits the reaction [4-amino-TEMPO inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[1,6-diaminohexane binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[Cadaverine binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[Putrescine binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[Spermine binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]]; Heparin inhibits the reaction [[trimethylenediamine binds to TEMPO] inhibits the reaction [MPO protein results in increased chemical synthesis of Hypochlorous Acid]] |
CTD |
PMID:34085520 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Msn |
moesin |
increases expression |
EXP |
Heparin results in increased expression of MSN protein |
CTD |
PMID:17488504 |
|
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression decreases expression |
ISO EXP |
Heparin results in increased expression of MYC protein Heparin results in decreased expression of MYC mRNA |
CTD |
PMID:2099192 PMID:11787776 PMID:16475731 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfatc3 |
nuclear factor of activated T-cells 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [Inositol 1,4,5-Trisphosphate results in increased expression of NFATC3 protein] |
CTD |
PMID:16259952 |
|
NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression |
ISO |
Heparin analog results in increased expression of NFE2L2 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Park7 |
Parkinsonism associated deglycase |
increases expression |
EXP |
Heparin results in increased expression of PARK7 protein |
CTD |
PMID:17488504 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
Heparin promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] |
CTD |
PMID:30377735 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
affects expression |
EXP |
Heparin affects the expression of PDGFB protein |
CTD |
PMID:8441232 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
decreases expression |
ISO |
Heparin results in decreased expression of PDGFRA mRNA |
CTD |
PMID:16945567 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
decreases expression |
EXP |
Heparin results in decreased expression of PDHB protein |
CTD |
PMID:17488504 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pf4 |
platelet factor 4 |
affects binding increases secretion |
ISO |
[Heparin binds to PF4 protein] which binds to FCGR2A protein; Heparin binds to PF4 protein Heparin results in increased secretion of PF4 protein |
CTD |
PMID:2437338 PMID:2709525 PMID:8282825 PMID:20162249 |
|
NCBI chr14:17,298,438...17,299,148
Ensembl chr14:17,298,308...17,299,365
|
|
G |
Pitpna |
phosphatidylinositol transfer protein, alpha |
increases expression |
EXP |
Heparin results in increased expression of PITPNA protein |
CTD |
PMID:17488504 |
|
NCBI chr10:60,430,712...60,473,564
Ensembl chr10:60,430,748...60,471,342
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression |
ISO |
Heparin results in increased expression of PLAT mRNA; Heparin results in increased expression of PLAT protein |
CTD |
PMID:14630814 PMID:16190367 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases expression |
ISO |
Heparin analog results in decreased expression of PLAU mRNA |
CTD |
PMID:26476401 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plg |
plasminogen |
multiple interactions |
ISO |
Heparin inhibits the reaction [PLG protein affects the degradation of CCL11 protein] |
CTD |
PMID:17384413 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Ppbp |
pro-platelet basic protein |
increases secretion |
ISO |
Heparin results in increased secretion of PPBP protein |
CTD |
PMID:2437338 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
increases activity |
ISO |
Heparin deficiency results in increased activity of PROC protein |
CTD |
PMID:7895349 |
|
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
decreases activity decreases expression |
ISO |
Heparin analog results in decreased activity of PSMB5 protein Heparin analog results in decreased expression of PSMB5 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
|
|
G |
Psmb6 |
proteasome 20S subunit beta 6 |
decreases expression |
ISO |
Heparin analog results in decreased expression of PSMB6 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr10:55,239,274...55,241,581
Ensembl chr10:55,239,241...55,241,586
|
|
G |
Psmb7 |
proteasome 20S subunit beta 7 |
decreases expression |
ISO |
Heparin analog results in decreased expression of PSMB7 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 3:22,357,777...22,417,748
Ensembl chr 3:22,354,698...22,417,937
|
|
G |
Psme1 |
proteasome activator subunit 1 |
increases expression |
EXP |
Heparin results in increased expression of PSME1 protein |
CTD |
PMID:17488504 |
|
NCBI chr15:29,069,012...29,071,888
Ensembl chr15:29,068,729...29,071,890
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of PTGS2 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
ISO |
Heparin results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:18674534 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Pxn |
paxillin |
decreases phosphorylation |
ISO |
Heparin results in decreased phosphorylation of PXN protein |
CTD |
PMID:18674534 |
|
NCBI chr12:41,060,791...41,107,962
Ensembl chr12:41,060,791...41,107,931
|
|
G |
Rac1 |
Rac family small GTPase 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of RAC1 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
Heparin analog results in decreased expression of and results in decreased phosphorylation of RB1 protein |
CTD |
PMID:20201787 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Heparin inhibits the reaction [arsenite affects the localization of RELA protein]; Heparin inhibits the reaction [TNF protein affects the localization of RELA protein] |
CTD |
PMID:10843908 PMID:26677073 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
S100a1 |
S100 calcium binding protein A1 |
affects expression |
EXP |
Heparin affects the expression of S100A1 protein |
CTD |
PMID:12186470 |
|
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
|
|
G |
S100a6 |
S100 calcium binding protein A6 |
affects expression increases expression |
EXP |
Heparin affects the expression of S100A6 protein Heparin results in increased expression of S100A6 protein |
CTD |
PMID:12186470 PMID:17488504 |
|
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
|
|
G |
S100b |
S100 calcium binding protein B |
affects expression |
EXP |
Heparin affects the expression of S100B protein |
CTD |
PMID:12186470 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sdc1 |
syndecan 1 |
decreases expression |
ISO |
Heparin analog results in decreased expression of SDC1 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
|
|
G |
Sdc2 |
syndecan 2 |
decreases expression |
ISO |
Heparin analog results in decreased expression of SDC2 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
|
|
G |
Sdc4 |
syndecan 4 |
increases expression |
ISO |
Heparin analog results in increased expression of SDC4 mRNA |
CTD |
PMID:26476401 |
|
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
|
|
G |
Sell |
selectin L |
decreases expression increases expression |
ISO |
Heparin results in decreased expression of SELL protein Heparin results in increased expression of SELL protein |
CTD |
PMID:8595612 PMID:8993250 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Selp |
selectin P |
multiple interactions increases expression |
ISO |
Heparin inhibits the reaction [F2 protein affects the localization of SELP protein]; Heparin promotes the reaction [Adenosine Diphosphate affects the localization of SELP protein] Heparin results in increased expression of SELP protein |
CTD |
PMID:9740346 PMID:10544909 |
|
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
|
|
G |
Septin2 |
septin 2 |
increases expression |
EXP |
Heparin results in increased expression of SEPTIN2 protein |
CTD |
PMID:17488504 |
|
NCBI chr 9:94,018,141...94,051,386
Ensembl chr 9:94,018,208...94,051,386
|
|
G |
Serpinc1 |
serpin family C member 1 |
decreases expression multiple interactions |
ISO |
Heparin deficiency results in decreased expression of SERPINC1 protein; Heparin results in decreased expression of SERPINC1 protein Heparin results in increased expression of [F2 protein binds to SERPINC1 protein] Heparin deficiency results in increased expression of [SERPINC1 protein binds to F2 protein] |
CTD |
PMID:73932 PMID:7895349 PMID:8122184 PMID:11869846 PMID:16961586 |
|
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
EXP |
Heparin inhibits the reaction [Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SERPINE1 protein]]; Heparin promotes the reaction [[Famotidine co-treated with Lipopolysaccharides] results in increased expression of SERPINE1 protein] |
CTD |
PMID:16401727 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Sfrp1 |
secreted frizzled-related protein 1 |
multiple interactions |
EXP |
Heparin promotes the reaction [Doxorubicin results in increased secretion of SFRP1 protein] |
CTD |
PMID:30377735 |
|
NCBI chr16:68,575,763...68,613,905
Ensembl chr16:68,575,763...68,614,286
|
|
G |
Slc5a3 |
solute carrier family 5 member 3 |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of SLC5A3 mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883
|
|
G |
Slk |
STE20-like kinase |
multiple interactions |
EXP |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of SLK mRNA] |
CTD |
PMID:16401727 |
|
NCBI chr 1:246,473,712...246,529,643
Ensembl chr 1:246,473,712...246,526,530
|
|
G |
Stip1 |
stress-induced phosphoprotein 1 |
increases expression |
EXP |
Heparin results in increased expression of STIP1 protein |
CTD |
PMID:17488504 |
|
NCBI chr 1:204,209,434...204,228,452
Ensembl chr 1:204,178,932...204,228,476
|
|
G |
Tagln2 |
transgelin 2 |
decreases expression |
EXP |
Heparin results in decreased expression of TAGLN2 protein |
CTD |
PMID:17488504 |
|
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions decreases expression |
EXP ISO |
Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of TFRC mRNA] Heparin results in decreased expression of TFRC protein |
CTD |
PMID:16401727 PMID:25633564 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
EXP |
Heparin results in decreased expression of TGFB1 mRNA |
CTD |
PMID:15149336 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
Heparin inhibits the reaction [TNF protein affects the localization of RELA protein] Heparin results in increased expression of TNF protein |
CTD |
PMID:10843908 PMID:17162433 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression |
ISO |
Heparin analog results in decreased expression of TP53 protein |
CTD |
PMID:20201787 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vegfa |
vascular endothelial growth factor A |
affects binding |
ISO |
Heparin binds to VEGFA protein alternative form |
CTD |
PMID:20376344 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
increases chemical synthesis |
ISO |
B3GNT2 protein results in increased chemical synthesis of Keratan Sulfate |
CTD |
PMID:12218059 |
|
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
increases chemical synthesis |
ISO |
B4GALT1 protein results in increased chemical synthesis of Keratan Sulfate |
CTD |
PMID:12218059 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
multiple interactions |
ISO |
CHST6 protein results in increased sulfation of and results in increased chemical synthesis of Keratan Sulfate CHST5 protein results in increased sulfation of and results in increased chemical synthesis of Keratan Sulfate |
CTD |
PMID:12218059 |
|
NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
affects degradation |
ISO |
GNS affects the degradation of Keratan Sulfate |
CTD |
PMID:3391615 |
|
NCBI chr 7:56,889,139...56,923,170
Ensembl chr 7:56,889,232...56,923,151
|
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
laurolactam binds to and results in decreased activity of AR protein |
CTD |
PMID:27633901 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
laurolactam binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:27633901 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
laurolactam binds to and results in decreased activity of NR3C1 protein |
CTD |
PMID:27633901 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
laurolactam binds to and results in decreased activity of PGR protein |
CTD |
PMID:27633901 |
|
NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|